Plains GP Holdings, L.P. (PAGP)
| Market Cap | 6.05B +67.6% |
| Revenue (ttm) | 45.26B -9.3% |
| Net Income | 196.00M +35.2% |
| EPS | 0.12 -84.2% |
| Shares Out | 233.00M |
| PE Ratio | 30.85 |
| Forward PE | 14.10 |
| Dividend | $1.67 (6.44%) |
| Ex-Dividend Date | May 1, 2026 |
| Volume | 2,093,735 |
| Open | 25.51 |
| Previous Close | 25.51 |
| Day's Range | 25.49 - 26.15 |
| 52-Week Range | 16.69 - 26.15 |
| Beta | 0.43 |
| Analysts | Buy |
| Price Target | 23.57 (-9.17%) |
| Earnings Date | May 8, 2026 |
About PAGP
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates through Crude Oil and Natural Gas Liquids (NGLs) segments. The company engages in the gathering and transporting crude oil using pipelines, trucks, and barges or railcars. It also provides terminalling, storage, and other related services. In addition, the company is involved in the natural gas processing and NGL fractionation, storage, transportation, and terminall... [Read more]
Financial Performance
In 2025, Plains GP Holdings's revenue was $44.26 billion, a decrease of -9.46% compared to the previous year's $48.89 billion. Earnings were $260.00 million, an increase of 152.43%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for PAGP stock is "Buy." The 12-month stock price target is $23.57, which is a decrease of -9.17% from the latest price.
News
Plains GP Holdings price target raised to $26 from $24 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $26 from $24 and keeps an Equal Weight rating on the shares.
Plains GP Holdings price target raised to $23 from $20 at Citi
Citi raised the firm’s price target on Plains GP Holdings (PAGP) to $23 from $20 and keeps a Neutral rating on the shares. The firm cites increased cash flow estimates…
Plains GP Holdings Proxy statement: Proxy filing
Plains GP Holdings filed a proxy statement on May 13, 2026, providing details for shareholder voting and corporate governance matters.
Plains All American, Plains GP complete Canadian NGL divestiture
Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) completed the previously announced sale of all of the issued and outstanding shares of Plains Midstream Canada ULC, the PAA…
Plains GP Holdings Proxy statement: Proxy filing
Plains GP Holdings filed a proxy statement on May 11, 2026, providing details for shareholder voting and corporate governance matters.
Plains GP Holdings Slides: Investor presentation
Plains GP Holdings has posted slides in relation to its latest quarterly earnings report, which was published on May 11, 2026.
Plains GP Holdings Earnings Call Transcript: Q1 2026
First quarter 2026 saw strong Adjusted EBITDA and raised full-year guidance, driven by robust crude and NGL segment performance, optimization, and favorable market conditions. Proceeds from the NGL sale will reduce debt, while cost efficiencies and capital discipline remain priorities.
Plains GP Holdings Earnings release: Q1 2026
Plains GP Holdings released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Plains GP Holdings Slides: Q1 2026
Plains GP Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.
Plains GP Holdings Quarterly report: Q1 2026
Plains GP Holdings has published its Q1 2026 quarterly earnings report on May 8, 2026.
Plains All American Pipeline and Plains GP Holdings Provide Update on the NGL Sale Process
HOUSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, “Plains”) today provided an update on the expected timin...
Plains GP Holdings Proxy statement: Proxy filing
Plains GP Holdings filed a proxy statement on April 10, 2026, providing details for shareholder voting and corporate governance matters.
Plains GP Holdings Proxy statement: Proxy filing
Plains GP Holdings filed a proxy statement on April 10, 2026, providing details for shareholder voting and corporate governance matters.
Plains GP Holdings price target raised to $21 from $18 at Barclays
Barclays raised the firm’s price target on Plains GP Holdings (PAGP) to $21 from $18 and keeps an Underweight rating on the shares. The firm says expectations for structurally higher…
Plains GP Holdings files to sell Class A shares representing limited partners
No amount was given.
Plains All American, Plains GP give update on Canadian NGL business divestiture
Plains All American (PAA) and Plains GP Holdings (PAGP) provided an update on the expected timing for completion of the Canadian NGL business divestiture to Keyera Corp. The transaction continues…
Plains All American Pipeline and Plains GP Holdings Provide Updated Timing for Completion of Sale of NGL Business
HOUSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, "Plains") today provided an update on the expected tim...
Plains GP Holdings Registration statement: Registration filing
Plains GP Holdings filed a registration statement on March 30, 2026, providing details about a securities offering with the SEC.
Plains GP Holdings initiated with a Buy at Truist
Truist initiated coverage of Plains GP Holdings (PAGP) with a Buy rating and $23 price target Plains is among the largest transporters and gatherers of crude and the “preeminent” crude…
Plains GP Holdings price target raised to $24 from $22 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $24 from $22 and keeps an Equal Weight rating on the shares. The firm updated estimates as…
Plains GP Holdings price target raised to $25 from $23 at Stifel
Stifel raised the firm’s price target on Plains GP Holdings (PAGP) to $25 from $23 and keeps a Buy rating on the shares. The firm, which is updating estimates post…
Plains GP Holdings price target raised to $20 from $17 at Citi
Citi raised the firm’s price target on Plains GP Holdings (PAGP) to $20 from $17 and keeps a Neutral rating on the shares. The firm upped estimates post the Q4…
Plains GP Holdings price target raised to $18 from $17 at Barclays
Barclays analyst Theresa Chen raised the firm’s price target on Plains GP Holdings (PAGP) to $18 from $17 and keeps an Underweight rating on the shares.
Plains GP Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 adjusted EBITDA reached $738M and $2.83B, respectively, as the company transitioned to a pure-play crude business, divested its NGL segment, and acquired the Cactus 3 pipeline. 2026 guidance calls for $2.75B EBITDA, flat Permian volumes, and continued cost savings.
Plains GP Holdings Annual report: Q4 2025
Plains GP Holdings has published its Q4 2025 annual report on February 6, 2026.